Cerus (CERS) EBT Growth (3y) (2013 - 2026)
Cerus (CERS) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 4.82% |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 61.06% |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn | -2.57% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 32.11% |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 53.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.58% |
| Dec 31, 2025 | 47.31% |
| Sep 30, 2025 | 26.15% |
| Jun 30, 2025 | 12.15% |
| Mar 31, 2025 | 14.45% |
| Dec 31, 2024 | 35.30% |
| Sep 30, 2024 | 38.63% |
| Jun 30, 2024 | 27.47% |
| Mar 31, 2024 | 17.87% |
| Dec 31, 2023 | 56.47% |
| Sep 30, 2023 | 19.99% |
| Jun 30, 2023 | 3.67% |
| Mar 31, 2023 | 1.75% |
| Dec 31, 2022 | 7.45% |
| Sep 30, 2022 | 22.13% |
| Jun 30, 2022 | 21.96% |
| Mar 31, 2022 | 13.30% |
| Dec 31, 2021 | 17.55% |
| Sep 30, 2021 | 4.37% |
| Jun 30, 2021 | -4.95% |